Clinical Trial Navigator - Executive Summary
A mobile-first AI-powered platform that simplifies clinical trial discovery for patients and caregivers, translating complex medical eligibility criteria into plain language and providing personalized trial matching with tracking and logistics support.
Core Problem Solved
Patients with chronic or serious conditions face an overwhelming challenge when searching for clinical trials. ClinicalTrials.gov lists over 450,000 studies with eligibility criteria written in complex medical jargon that's incomprehensible to non-medical readers. This creates a significant barrier to accessing potentially life-changing treatment options.
The current process is broken: patients don't know relevant trials exist for their condition, can't understand eligibility requirements, have no easy way to track multiple trials, and face hidden geographic and logistical barriers. This results in 80% of clinical trials failing to meet recruitment targets, delaying medical research by an average of 6 months per trial.
Primary Audience
Primary: 50 million Americans with chronic or serious conditions (cancer, rare diseases, autoimmune disorders) who are actively seeking treatment options beyond standard care. These patients are typically aged 30-70, tech-savvy enough to use mobile apps, and highly motivated to find alternative treatments.
Secondary: Caregivers (15 million in the US) researching on behalf of family members, particularly for elderly parents or children with rare conditions. These users often have higher time constraints but are equally motivated to find solutions.
Market Size Breakdown
TAM
$2B+
Global clinical trial recruitment market
SAM
$500M
US patient-facing clinical trial discovery
SOM
$50M
3-year target (10% SAM)
*Based on 50M chronic condition patients in US, $100 average annual value per engaged user, and 10% market penetration in 3 years.
Market Timing ("Why Now?")
Technology Enablers
- LLMs can now accurately parse complex medical criteria
- FHIR standards enable secure health data integration
- Mobile-first PWAs provide app-like experience without downloads
- ClinicalTrials.gov API provides free, comprehensive data
Behavioral Shifts
- Patients increasingly research their own conditions online
- Growing acceptance of telemedicine and digital health tools
- Pharma facing increasing pressure to improve recruitment
- COVID-19 accelerated acceptance of clinical research participation
Competitive Positioning
Patient-Centricity
(Official Source)
(Pharma-Focused)
(Patient-First)
Key Differentiators
- Plain Language: AI-generated patient briefs explain trials in simple terms
- Personalized Matching: Percentage-based eligibility scoring with clear explanations
- Logistics Support: Travel planning, insurance checks, and coordinator contact
- Mobile-First: PWA with offline capability for on-the-go access
- Patient Advocacy: Transparent about partnerships, patient interests first
Financial Snapshot
MVP Cost
$150K
3-4 months development
Revenue Model
Freemium SaaS ($9.99/month premium) + B2B lead generation
Break-Even
18-24
Months to profitability
LTV:CAC
3.5:1
Target ratio
Top 3 Highlights
Massive Untapped Market
With 50 million Americans living with chronic conditions and 80% of clinical trials failing to meet recruitment targets, there's a critical gap in patient-centric trial discovery tools. The $2B+ clinical trial recruitment market is ripe for disruption with a solution that puts patients first.
AI-Powered Medical Translation
Leveraging large language models to translate complex medical eligibility criteria into plain language patient briefs solves a fundamental usability barrier. This AI advantage creates a defensible moat while improving accessibility for non-medical users.
Dual Revenue Streams
The freemium B2C model combined with B2B lead generation for pharma and hospital systems creates multiple monetization paths. This diversified approach reduces risk while capturing value from both sides of the clinical trial ecosystem.
Overall Viability Scores
Strong viability across all dimensions with clear path to market. The combination of proven demand, technical feasibility, and dual revenue streams creates an attractive opportunity with significant social impact potential.
Critical Success Factors
1. Medical Accuracy
Maintain >95% accuracy in eligibility criteria translation to prevent misinformation and build trust with users and medical professionals.
2. User Engagement
Achieve 30%+ 30-day retention through habit-forming features (notifications, progress tracking) and community support elements.
3. Pharma Partnerships
Secure 5+ pharma/CRO partnerships within 12 months to validate B2B revenue model and provide exclusive trial access to users.
Key Risks & Mitigations
Success Metrics (First 6 Months)
Monthly Active Users
10,000+
Indicates sustained engagement beyond initial curiosity
Premium Conversion Rate
5%+
Validates willingness to pay for premium features
Coordinator Contacts
1,000+
Measures real-world impact on trial recruitment
Recommended Next Steps
-
Week 1-2: Validate with Patients
- Conduct 30 interviews with chronic condition patients
- Test prototype with 50 users from patient advocacy groups
- Refine value proposition based on feedback
-
Week 3-4: Build Landing Page & Waitlist
- Create high-conversion landing page with demo video
- Launch waitlist campaign targeting 1,000 signups
- Partner with 3 patient advocacy groups for promotion
-
Week 5-12: Develop MVP
- Build core matching engine with ClinicalTrials.gov API
- Implement AI-powered plain language summaries
- Develop basic trial tracker dashboard
- Create mobile-first PWA with offline capability
-
Week 13-14: Private Beta Testing
- Onboard 200 waitlist users for beta testing
- Collect detailed feedback on usability and features
- Iterate based on user behavior data
-
Week 15-16: Soft Launch
- Launch on Product Hunt and relevant subreddits
- Partner with 5 patient advocacy groups for promotion
- Begin pharma partnership outreach
-
Month 5-6: Scale & Fundraise
- Expand to 10,000+ MAU through targeted campaigns
- Secure first pharma/CRO partnership
- Begin seed fundraising round